In Vitro Cytokinesis-Block Micronucleus Assay | PraxiLabs

In Vitro Cytokinesis-Block Micronucleus Assay Virtual Lab Simulation

Biology | Toxicology | Biochemistry | Proteomics | Pharmacology

As Featured In

In Vitro Cytokinesis-Block Micronucleus Assay Virtual Lab

General Aim of CBMN Assay

This experiment aims at detecting the damage of chromosomes, both chromosome loss, and chromosome breakage, to evaluate the induction of genotoxic effects of nanoparticles and nanomaterials using the light microscope.

CBMN Assay Experiment Method

In Vitro Cytokinesis-Block Micronucleus Assay using Microscopy

Learning Objectives of CBMN Assay Experiment

  • Successfully handle the required instruments and consumables needed in the experiment.

  • Check the confluence and count cells under the microscope.

  • Dilute the cells to a specific count suitable for seeding in the 24-well plate.

  • Calculate the concentration of tested chemicals and prepare the calculated doses in the cell culture medium.

  • Treat cells with the genotoxic agent(s) or nanoparticles and observe under the microscope Harvest cells, fix them and stain with Giemsa stain.

  • Analyze cells by light microscope and evaluate analyzed data.

  • Represent and interpret the resulting data graphically using dot plots.

Theory of CBMN Assay Experiment

In genetics, genotoxicity describes the property of chemical agents that damages the genetic information within a cell causing mutations, which may lead to cancer. While genotoxicity is often confused with mutagenicity, all mutagens are genotoxic, whereas not all genotoxic substances are mutagenic. The alteration can have direct or indirect effects on the DNA: the induction of mutations, mistimed event activation, and direct DNA damage leading to mutations. The permanent, heritable changes can affect either somatic cells of the organism or germ cells to be passed on to future generations. Cells prevent expression of the genotoxic mutation by either DNA repair or apoptosis; however, the damage may not always be fixed leading to mutagenesis.

Principle of Micronucleus Assay

The cytokinesis-block micronucleus assay (CBMN) is a sensitive and simple indicator of chromosome damage, both chromosome loss and chromosome breakage, which also provides information on cell cycle progression and cytotoxicity. MN are small nuclei separated from the main nucleus and contain chromosomes or chromosome fragments, derived from mitotic spindle dysfunction or acentric fragments. Because they are expressed in cells that have completed nuclear division, they are ideally scored in the binucleated stage of the cell cycle. 

 

 

PraxiLabs is Recognized Worldwide

Customers Love PraxiLabs

“With the onset of the COVID-19 pandemic, we found ourselves in a situation that forced us to act quickly to find the best solution available to provide our students with a quality molecular genetics laboratory experience.”

Korri Thorlacius, B.Sc.
Biology Laboratory Instructor
Biology Department
Kwantlen Polytechnic University

'' Although there are now several vendors offering virtual reality software for physics labs, there is only one that offers a realistic, I feel like I’m in a real lab, solution: PraxiLabs.''

Dr.‌ ‌William‌ ‌H.‌ ‌Miner,‌ ‌Jr.‌ ‌
Professor‌ ‌of‌ ‌Physics‌ ‌
Palm‌ ‌Beach‌ ‌State‌ ‌College‌ ‌
Boca‌ ‌Raton,‌ ‌FL‌

" PraxiLabs offered my students a chance to actively engage with the material. Instead of watching videos on a topic, they could virtually complete labs and realize the practical applications of class topics. This is a quality alternative to in-person labs."

Crys Wright
Teaching Assistant
Texas A&M University, USA

"Great user experience and impressive interaction, I am very pleased to have tried the simulations and will continue to do so."

Dr. Khaled M Goher
Lecturer in Biomedical Engineering
Aston University, UK

The #1 Science Virtual Labs used by Educational Institutions

Explore More Interactive 3D Virtual Simulations

Designed for Safety and Engagement

Find out how PraxiLabs keeps students engaged and improves learning outcomes